PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: ChemImage Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Gateway Analytical to Present Latest Methodologies for Glass Delamination Analysis at Annual Meeting of Pharmaceutical Scientists - Gateway Analytical announced that they will give a scientific poster presentation on glass delamination analysis in addition to exhibiting at the upcoming 2015 AAPS Annual Meeting and Exposition in Orlando, Florida - GatewayAnalytical.com
Gateway Analytical to Present Latest Methodologies for Glass Delamination Analysis at Annual Meeting of Pharmaceutical Scientists

 

NewswireToday - /newswire/ - Pittsburgh, PA, United States, 2015/10/22 - Gateway Analytical announced that they will give a scientific poster presentation on glass delamination analysis in addition to exhibiting at the upcoming 2015 AAPS Annual Meeting and Exposition in Orlando, Florida - GatewayAnalytical.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Gateway Analytical announced today that they will give a scientific poster presentation on glass delamination analysis in addition to exhibiting at the upcoming 2015 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in Orlando, Florida. The AAPS Annual Meeting and Exposition is one of the largest gatherings of top scientists, CROs and CMOs in pharmaceutical, biotechnology, and medical device industries. This conference focuses on the latest industry developments and advancement to help companies push their research and development further.

At the conference, Emily Landsperger, Scientist at Gateway Analytical, will present a scientific poster session entitled,"Challenges in Counting and Sizing Glass Lamellae Using an Automated Method" during the October 27th session. The presentation will discuss a comprehensive of what glass delamination is, how it can occur, and the different methodologies that can be utilized to determine their drug product's stability in a specific type of vial, or other glass container. Conference attendees are encouraged to continue the conversation at Gateway Analytical's exhibit, booth #854.

"We are excited to discuss our service offerings with the AAPS community in order to determine how Gateway Analytical can assist them with day-to-day issues faced during pharmaceutical product development, such as identifying foreign particulates or glass delamination analysis," said David Exline, Senior Vice President at Gateway Analytical. "We have expanded our capabilities in order to meet customer and industry demand, giving companies the option to choose one analytical laboratory to support all their outsourcing needs, and streamline turnaround time in the process."

Gateway Analytical is a full service, cGMP compliant, ISO 9001:2008 certified, ISO 17025:2005 certified, DEA licensed, FDA registered and inspected laboratory with specialized expertise in techniques for chemically specific analysis and particulate contamination identification. For more information on Gateway Analytical services, contact Paige Cohen, Sales Development Associate, at cohenp[.]gatewayanalytical.com.

About Gateway Analytical

Based in Gibsonia, Pa., Gateway Analytical, LLC (gatewayanalytical.com) offers analytical testing services to companies in need of high-quality laboratory analysis by providing additional testing resources, specialized capabilities and comprehensive testing. Through conventional and innovative testing methods, the company supplies a number of key services for the pharmaceutical, materials science, medical device and forensic industries including; foreign particulate identification, glass delamination analysis, chemically-specific particle sizing, materials characterization, wear debris testing and trace evidence analysis.

Gateway Analytical is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.

About ChemImage

ChemImage Corporation (chemimage.com), a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.

ChemImage's headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: ChemImage Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Gateway Analytical to Present Latest Methodologies for Glass Delamination Analysis at Annual Meeting of Pharmaceutical Scientists

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Tifanie Tiberio - ChemImage.com 
412-241-7335 x269 tiberiot[.]chemimage.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ChemImage Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From ChemImage Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)